StockTipsArenaBeta

BUY Mankind Pharma Limited — Motilal Oswal

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byMotilal OswalHorizon: NA (inferred 1 year)29 Apr 2026via Institutional / Brokerage Research

Entry₹2,256.8Inferred
Target₹2,640
Total upside +16.98% (call closed)
Stop lossNot given
Exit₹2,64029 Jul 2026, 12:07 pm
Target hit+16.98%0.00%upside left
Follow Motilal Oswal for new calls(62% target hit, 1113 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 8 active Long-term calls on MANKINDSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 29 Jul 2026
7 supporting7 neutral0 opposing
Supports the BUY call (7)

Mankind Pharma completes sale of Broadway Hospitality stake for ₹49 crore

NewsGoogle News·27 Jul · yesterday

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·9 Jul · 3w ago

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·7 Jul · 3w ago

Neutral / worth noting (7)

Mankind Pharma Limited's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly-owned subsidiary in Netherlands for R&D inve

NSE · Acquisition·11 Jul · 2w ago

(opens in new tab)

Mankind Pharma Ltd's Board approved the incorporation of a wholly owned subsidiary in the Netherlands.

BSE · Company Update·11 Jul · 2w ago

(opens in new tab)

Mankind Pharma Limited's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly owned subsidiary in Netherlands for R&D inve

NSE · Outcome of Board Meeting·11 Jul · 2w ago

(opens in new tab)

Mankind Pharma's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly-owned subsidiary in Netherlands for R&D investments.

BSE · Others·11 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Motilal Oswal

Every call and its outcome